Ingevity Corporation $NGVT Stock Position Cut by Royce & Associates LP

Royce & Associates LP trimmed its position in Ingevity Corporation (NYSE:NGVT – Free Report) by 8.2% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 863,539 shares of the company’s stock after selling 76,878 shares during the period. Ingevity comprises about 0.6% of Royce & Associates LP’s portfolio, making the stock its 23rd largest holding. Royce & Associates LP’s holdings in Ingevity were worth $61,095,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of NGVT. Frazier Financial Advisors LLC acquired a new position in shares of Ingevity during the second quarter valued at approximately $37,000. Global Retirement Partners LLC acquired a new stake in shares of Ingevity in the second quarter worth approximately $45,000. Harbor Investment Advisory LLC acquired a new stake in shares of Ingevity in the second quarter worth approximately $71,000. Public Employees Retirement System of Ohio acquired a new stake in shares of Ingevity in the second quarter worth approximately $75,000. Finally, Assetmark Inc. increased its position in shares of Ingevity by 9.6% during the first quarter. Assetmark Inc. now owns 1,584 shares of the company’s stock worth $113,000 after purchasing an additional 139 shares in the last quarter. 91.59% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Ingevity

In other news, CEO David Li sold 5,000 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $75.83, for a total value of $379,150.00. Following the completion of the sale, the chief executive officer directly owned 120,636 shares in the company, valued at $9,147,827.88. This represents a 3.98% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.88% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several research analysts recently commented on NGVT shares. Weiss Ratings raised Ingevity from a “hold (c-)” rating to a “hold (c)” rating in a research note on Wednesday, November 4th. Wall Street Zen lowered Ingevity from a “buy” rating to a “hold” rating in a report on Saturday, November 7th. Two investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $80.00.

Read Our Latest Analysis on Ingevity

Ingevity Price Performance

NYSE NGVT traded down $0.11 during trading hours on Friday, hitting $61.86. 233,948 shares of the company’s stock traded hands, compared to its average volume of 402,029. Ingevity Corporation has a 52-week low of $46.38 and a 52-week high of $79.29. The company has a market capitalization of $2.09 billion, a PE ratio of 36.39 and a beta of 1.12. The company has a debt-to-equity ratio of 15.70, a current ratio of 1.48 and a quick ratio of 1.05. The firm’s 50-day moving average is $69.67 and its 200-day moving average is $71.09.

Ingevity (NYSE:NGVT – Get Free Report) last released its quarterly earnings data on Wednesday, November 4th. The company reported $1.63 EPS for the quarter, beating analysts’ consensus estimates of $1.56 by $0.07. Ingevity had a net margin of 5.28% and a return on equity of 405.38%. The company had revenue of $305.10 million during the quarter, compared to the consensus estimate of $303.91 million. Equities analysts forecast that Ingevity Corporation will post 5.40 EPS for the current fiscal year.

Ingevity Company Profile

(Free Report)

Ingevity is a specialty chemicals and materials company headquartered in North Charleston, South Carolina. It develops and manufactures high-performance activated carbon and specialty chemical products for industrial and consumer applications. Its activated carbon products are used in vehicle fuel-vapor emission control and other applications. The company also makes specialty chemicals and polymer materials used in areas such as pavement technologies, coatings, adhesives and elastomers. Ingevity serves customers in markets around the world.

Further Reading

Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Corporation (NYSE:NGVT – Free Report).

Institutional Ownership by Quarter for Ingevity (NYSE:NGVT)

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.